Human clinical research demonstrates that just 40 mg of UC-II® supports joint comfort, flexibility and mobility.* Just 40 mg once-a-day offers your consumers the convenience they want from dietary supplements and will ultimately help increase consumer compliance.
New UC-II randomized, double-blind, placebo-controlled study was conducted on 186 subjects for 180 days. Clinical findings were presented at the Scripps 12th Annual Natural Supplements Conference in San Diego, CA. UC-II® provided statistically significant reduction in WOMAC scores compared to placebo in increasing joint function. The Glucosamine hydrochloride + chondroitin sulfate group did not achieve statistical significance versus placebo for any of the clinical endpoints. Two previous published research studies, including research in healthy subjects also demonstrates joint-health benefits for UC-II®.
UC-II® consists of collagen with undenatured type II collagen, a FDA-notified and published new dietary ingredient (NDI). UC-II® is manufactured in a GMP-certified facility and has been determined GRAS for use in foods and beverages.
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to cure, mitigate, treat or prevent any disease.